Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Oct 24;92(22):10157–10161. doi: 10.1073/pnas.92.22.10157

Agonist-induced desensitization of dopamine D1 receptor-stimulated adenylyl cyclase activity is temporally and biochemically separated from D1 receptor internalization.

G Y Ng 1, J Trogadis 1, J Stevens 1, M Bouvier 1, B F O'Dowd 1, S R George 1
PMCID: PMC40755  PMID: 7479745

Abstract

The regulation of the dopamine D1 receptor was investigated by using c-myc epitope-tagged D1 receptors expressed in Sf9 (fall armyworm ovary) cells. Treatment of D1 receptors with 10 microM dopamine for 15 min led to a loss of the dopamine-detected high-affinity state of the receptor accompanying a 40% reduction in the ability of the receptor to mediate maximal dopamine stimulation of adenylyl cyclase activity. After 60 min of agonist exposure, 45 min after the occurrence of desensitization, 28% of the cell surface receptors were internalized into an intracellular light vesicular membrane fraction as determined by radioligand binding and supported by photoaffinity labeling, immunocytochemical staining, and immunoblot analysis. Pretreatment of cells with concanavalin A or sucrose completely blocked agonist-induced D1 receptor internalization without preventing agonist-induced desensitization, indicating a biochemical separation of these processes. Collectively, these findings indicate that the desensitization of D1 receptor-coupled adenylyl cyclase activity and D1 receptor internalization are temporarily and biochemically distinct mechanisms regulating D1 receptor function following agonist activation.

Full text

PDF
10157

Images in this article

10159Fig. 2
on p.10159
10160Fig. 3
on p.10160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates M. D., Caron M. G., Raymond J. R. Desensitization of DA1 dopamine receptors coupled to adenylyl cyclase in opossum kidney cells. Am J Physiol. 1991 Jun;260(6 Pt 2):F937–F945. doi: 10.1152/ajprenal.1991.260.6.F937. [DOI] [PubMed] [Google Scholar]
  2. Bates M. D., Olsen C. L., Becker B. N., Albers F. J., Middleton J. P., Mulheron J. G., Jin S. L., Conti M., Raymond J. R. Elevation of cAMP is required for down-regulation, but not agonist-induced desensitization, of endogenous dopamine D1 receptors in opossum kidney cells. Studies in cells that stably express a rat cAMP phosphodiesterase (rPDE3) cDNA. J Biol Chem. 1993 Jul 15;268(20):14757–14763. [PubMed] [Google Scholar]
  3. Dohlman H. G., Thorner J., Caron M. G., Lefkowitz R. J. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem. 1991;60:653–688. doi: 10.1146/annurev.bi.60.070191.003253. [DOI] [PubMed] [Google Scholar]
  4. Emrich T., Förster R., Lipp M. Topological characterization of the lymphoid-specific seven transmembrane receptor BLR1 by epitope-tagging and high level expression. Biochem Biophys Res Commun. 1993 Nov 30;197(1):214–220. doi: 10.1006/bbrc.1993.2463. [DOI] [PubMed] [Google Scholar]
  5. Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985 Dec;5(12):3610–3616. doi: 10.1128/mcb.5.12.3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lohse M. J., Benovic J. L., Caron M. G., Lefkowitz R. J. Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem. 1990 Feb 25;265(6):3202–3211. [PubMed] [Google Scholar]
  7. Mouillac B., Caron M., Bonin H., Dennis M., Bouvier M. Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. J Biol Chem. 1992 Oct 25;267(30):21733–21737. [PubMed] [Google Scholar]
  8. Ng G. Y., George S. R., Zastawny R. L., Caron M., Bouvier M., Dennis M., O'Dowd B. F. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry. 1993 Nov 2;32(43):11727–11733. doi: 10.1021/bi00094a032. [DOI] [PubMed] [Google Scholar]
  9. Ng G. Y., Mouillac B., George S. R., Caron M., Dennis M., Bouvier M., O'Dowd B. F. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol. 1994 Mar 15;267(1):7–19. doi: 10.1016/0922-4106(94)90219-4. [DOI] [PubMed] [Google Scholar]
  10. Niznik H. B., Jarvie K. R., Bzowej N. H., Seeman P., Garlick R. K., Miller J. J., Jr, Baindur N., Neumeyer J. L. Photoaffinity labeling of dopamine D1 receptors. Biochemistry. 1988 Oct 4;27(20):7594–7599. doi: 10.1021/bi00420a004. [DOI] [PubMed] [Google Scholar]
  11. O'Dowd B. F. Structures of dopamine receptors. J Neurochem. 1993 Mar;60(3):804–816. doi: 10.1111/j.1471-4159.1993.tb03224.x. [DOI] [PubMed] [Google Scholar]
  12. Trogadis J. E., Ng G. Y., O'Dowd B. F., George S. R., Stevens J. K. Dopamine D1 receptor distribution in Sf9 cells imaged by confocal microscopy: a quantitative evaluation. J Histochem Cytochem. 1995 May;43(5):497–506. doi: 10.1177/43.5.7730588. [DOI] [PubMed] [Google Scholar]
  13. Waldo G. L., Northup J. K., Perkins J. P., Harden T. K. Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization. J Biol Chem. 1983 Nov 25;258(22):13900–13908. [PubMed] [Google Scholar]
  14. Wang H. Y., Berrios M., Malbon C. C. Indirect immunofluorescence localization of beta-adrenergic receptors and G-proteins in human A431 cells. Biochem J. 1989 Oct 15;263(2):519–532. doi: 10.1042/bj2630519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yu S. S., Lefkowitz R. J., Hausdorff W. P. Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem. 1993 Jan 5;268(1):337–341. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES